• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Targacept

edit

Targacept, Inc. is a biopharmaceutical company developing a diverse pipeline of NNR TherapeuticsTM. NNR Therapeutics selectively target neuronal nicotinic receptors, or NNRs. NNRs are found on nerve cells throughout the nervous system and serve as key regulators of nervous system activity.

Recent Milestones

edit

• 
  Targacept added Merouane Bencherif as Senior Vice President, Preclinical Research.
  Posted 2/23/13 at 2:02am
• 
  Targacept added Stephen A. Hill as President and CEO.
  Posted 11/30/12 at 9:48pm

Videos

Screenshots

edit

Above: Targacept
Uploaded: 12/1/12

Sources